Samsung Pharmaceutical Co., Ltd. (KOSE:A001360) agreed to sell 17.13% stake in Medizen Humancare Co.,Ltd. for KRW 2 billion on September 1, 2015. The Board of Directors of Samsung Pharmaceutical passed a resolution for the transaction on September 1, 2015. The transaction is expected to close on October 8, 2015.

Samsung Pharmaceutical Co., Ltd. (KOSE:A001360) completed the sale of 17.13% stake in Medizen Humancare Co.,Ltd. on October 5, 2015.